The significance of disulfide bonding in biological activity of HB-EGF, a mutagenesis approach.

Biochemical and Biophysical Research Communications
J T HoskinsP A Harding

Abstract

A site-directed mutagenesis approach was taken to disrupt each of 3 disulfide bonds within human HB-EGF by substituting serine for both cysteine residues that contribute to disulfide bonding. Each HB-EGF disulfide analogue (HB-EGF-Cys/Ser(108/121), HB-EGF-Cys/Ser(116/132), and HB-EGF-Cys/Ser(134/143)) was cloned under the regulation of the mouse metallothionein (MT) promoter and stably expressed in mouse fibroblasts. HB-EGF immunoreactive proteins with M(r) of 6.5, 21 and 24 kDa were observed from lysates of HB-EGF and each HB-EGF disulfide analogue. HB-EGF immunohistochemical analyses of each HB-EGF stable cell line demonstrated ubiquitous protein expression except HB-EGF-Cys/Ser(108/121) and HB-EGF-Cys/Ser(116/132) stable cell lines which exhibited accumulated expression immediately outside the nucleus. rHB-EGF, HB-EGF, and HB-EGF(134/143) proteins competed with 125I-EGF in an A431 competitive binding assay, whereas HB-EGF-Cys/Ser(108/121) and HB-EGF-Cys/Ser(116/132) failed to compete. Each HB-EGF disulfide analogue lacked the ability to stimulate tyrosine phosphorylation of the 170 kDa EGFR. These results suggest that HB-EGF-Cys/Ser(134/143) antagonizes EGFRs.

References

Jan 11, 1991·Archives of General Psychiatry·W T CarpenterA Breier
Nov 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·G T MontelioneH A Scheraga
Jan 1, 1994·Growth Factors·L C GroenenA W Burgess
Aug 1, 1996·Protein Expression and Purification·K M DavisG E Besner
Jan 15, 1997·The EMBO Journal·M A LemmonJ Schlessinger
Mar 19, 1999·Protein Science : a Publication of the Protein Society·K J BarnhamR S Norton
May 17, 2000·Proteins·B A Sampoli Benitez, E A Komives
Feb 2, 2002·The Journal of Biological Chemistry·Susan Wohler SunnarborgDavid C Lee
Mar 4, 2003·Nature Reviews. Molecular Cell Biology·Lars Ellgaard, Ari Helenius
Nov 5, 2003·The Journal of Cell Biology·Daisuke NanbaShigeki Higashiyama

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.